Kursinformationen zu Lord Abbett Global Health Care Fund - Class IF USD Accumulating

Lord Abbett Global Health Care Fund - Class IF USD Accumulating
Valor 127167042
13.53USD0.04USD+0.30%
28.09.2026
Kursdaten28.09.2026
NAV in CHF
13.53
Tagesveränderung relativ
+0.30%
Tagesveränderung absolut
0.04
NAV Vortag
13.49
Letzter Handel
28.09.2026
Konditionen
Ausgabekommissionen
+0.00%
Verwaltungsgebühr
+0.25%
OGC
0.00 %
Dokumente
Monatsbericht
-
Halbjahresbericht
-
Jahresbericht
-
Vollständiger Fondsprospekt
-
Gesetzl. Publikationen
PDF
Fondsstrategie

The investment objective of the Fund is to seek long-term capital appreciation. Under normal conditions, the Fund pursues its investment objective by investing at least 80% of its net assets in equity and equity related securities of health care-related companies. The Fund considers health care-related companies to be those companies that operate in, or are related to, the major subsectors of the health care sector, including pharmaceuticals, biotechnology, health care technology, life sciences tools and services, health care equipment and supplies, and health care providers and services. Equity securities in which the Fund may invest include common stocks, preferred stocks, equity interests in trusts (including real estate investment trusts and privately offered trusts), partnerships, joint ventures, limited liability companies and other instruments convertible or exercisable into the foregoing such as convertible bonds (excluding contingent convertible bonds) and warrants. The Fund may invest in U.S. and non-U.S. (including up to 20% of net assets in emerging market) companies, the securities of which may be traded on U.S. or non-U.S. securities exchanges (or may not be traded on any securities exchange), may be denominated in the U.S. dollar or other currencies, and may include American Depositary Receipts and other similar depositary receipts. The Fund also may invest in supranational organizations. The Fund has no geographical limitations on investments or any limit on the amount of assets that may be invested in any single country.

Kursentwicklung / Kennzahlen
ZeitraumPerformanceVolatilitätSharpe RatioBester MonatSchlecht. MonatMax Verlust
YTD+7.81%+18.90%+0.43%+7.60%-4.64%-11.28%
6 Monate+18.06%+19.44%+1.90%+7.60%-4.64%-6.67%
1 Jahr+24.47%+18.05%+1.22%+10.09%-4.64%-13.03%
3 Jahre------
5 Jahre------
Stammdaten
ISIN
IE000F6KJMW8
Valor
127167042
Währung
USD
Fondstyp
Aktienfonds
Ertragsart
thesaurierend
Anlageschwerpunkt
Branche Gesundheit/Pharma
Anlageregion
weltweit
Domizil
-
Vertriebszulassung
Irland
Auflagedatum
20.06.2023
Fondsvolumen
2'806'709.33
Geschäftsjahresbeginn
01.02.2026
Benchmark
-
Fondsgesellschaft
Lord Abbett (IE)
Grösste Positionen
Eli Lilly & Co
8.80 %
Argenx SE
4.10 %
AstraZeneca PLC
3.50 %
Gilead Sciences Inc
3.50 %
Tarsus Pharmaceuticals Inc
3.10 %
Natera Inc
3.00 %
Guardant Health Inc
2.80 %
Cencora Inc
2.70 %
EssilorLuxottica SA
2.70 %
Abivax SA
2.40 %
Fondszusammensetzung nach Branchen
Pharmazeutika/Biotechnologie
39.30 %
Pharmazeutika Produktion
26.70 %
Gesundheitswesen
17.80 %
Medizinische Produkte/Instrumente
14.30 %